| NE | neuroendocrine |
| NST | non-special type |
| NET | neuroendocrine tumor |
| NEC | neuroendocrine carcinoma |
| WHO | World Health Organization |
| NEN | neuroendocrine neoplasm |
| HER2 | human epidermal growth factor type 2 |
| HR | hormone receptor |
| CDK4/6 | cyclin-dependent kinase 4/6 |
| IHC | immunohistochemistry |
| IBC-NST | invasive breast cancer of no special type |
| Br-NENs | neuroendocrine neoplasms of the breast |
| CGA | chromogranin A |
| SYN | synaptophysin |
| LCNEC | large cell neuroendocrine carcinoma |
| SCNEC | small cell neuroendocrine carcinoma |
| ER | estrogen receptor |
| PgR | progesterone receptor |
| T-DM1 | trastuzumab-emtansine |
| ADC | antibody-drug conjugate |
| PPRT | Peptide receptor radionuclide therapy |